85 related articles for article (PubMed ID: 2053856)
21. Eosinophil and eosinophil cationic protein in allergic rhinitis.
Beppu T; Ohta N; Gon S; Sakata K; Inamura K; Fukase S; Kimura Y; Koike Y
Acta Otolaryngol Suppl; 1994; 511():221-3. PubMed ID: 8203234
[TBL] [Abstract][Full Text] [Related]
22. The distribution of eosinophil cationic protein positive eosinophils in the nasal mucosa of the nasal allergy patients.
Naito K; Takeda N; Yokoyama N; Ibata K; Ishihara M; Senoh Y; Iwata S
Auris Nasus Larynx; 1993; 20(3):197-204. PubMed ID: 8297267
[TBL] [Abstract][Full Text] [Related]
23. Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes.
Klementsson H; Venge P; Andersson M; Pipkorn U
Acta Otolaryngol; 1991; 111(4):776-84. PubMed ID: 1950542
[TBL] [Abstract][Full Text] [Related]
24. Monitoring nasal allergic inflammation by measuring the concentration of eosinophil cationic protein and eosinophils in nasal secretions.
Wang D; Clement P; Smitz J; de Waele M; Derde MP
Allergy; 1995 Feb; 50(2):147-51. PubMed ID: 7604937
[TBL] [Abstract][Full Text] [Related]
25. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.
Sedgwick JB; Calhoun WJ; Gleich GJ; Kita H; Abrams JS; Schwartz LB; Volovitz B; Ben-Yaakov M; Busse WW
Am Rev Respir Dis; 1991 Dec; 144(6):1274-81. PubMed ID: 1741538
[TBL] [Abstract][Full Text] [Related]
26. Nitrogen dioxide increases eosinophil activation in the early-phase response to nasal allergen provocation.
Wang JH; Duddle J; Devalia JL; Davies RJ
Int Arch Allergy Immunol; 1995; 107(1-3):103-5. PubMed ID: 7613114
[TBL] [Abstract][Full Text] [Related]
27. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge.
Jacobi HH; Poulsen LK; Reimert CM; Skov PS; Ulfgren AK; Jones I; Elfman LB; Malling HJ; Mygind N
Int Arch Allergy Immunol; 1998 May; 116(1):53-9. PubMed ID: 9623510
[TBL] [Abstract][Full Text] [Related]
28. Major basic protein, eosinophil cationic protein, and arylsulfatase in nasal secretions of patients with Japanese cedar pollinosis.
Nishioka K; Ogawa T; Saito C; Nishioka S; Nakagawa F; Ohomichi T; Masuda Y
Acta Med Okayama; 1995 Feb; 49(1):29-33. PubMed ID: 7762407
[TBL] [Abstract][Full Text] [Related]
29. Nasal IL-16 and MIP-1 alpha in late-phase allergic response.
Kramer MF; Ostertag P; Pfrogner E; Rasp G
Allergy Asthma Proc; 2001; 22(3):127-32. PubMed ID: 11424872
[TBL] [Abstract][Full Text] [Related]
30. Tissue density and state of activation of eosinophils in the nasal mucosa of allergic and nonallergic rhinopathic patients.
Kawabori S; Nakamura A; Kanai N
Allergy; 1994 Feb; 49(2):81-5. PubMed ID: 8172363
[TBL] [Abstract][Full Text] [Related]
31. Allergen-induced inflammation in the nose: a comparison of acute and repeated low-dose allergen exposure.
Roquat A; Ihre E; van Hage-Hamsten M; Halldén G; Zetterström O
Allergy; 1996 Jan; 51(1):42-8. PubMed ID: 8721527
[TBL] [Abstract][Full Text] [Related]
32. [Immunohistochemical study of inferior turbinate of nasal allergy with reference to eosinophils].
Takamura H
Nihon Jibiinkoka Gakkai Kaiho; 1994 Jan; 97(1):61-6. PubMed ID: 8176538
[TBL] [Abstract][Full Text] [Related]
33. [Immunohistological study of the nasal mucosa in latent allergic patients].
Takasaki K; Yoshimi R; Takamura H; Kumagami H
Nihon Jibiinkoka Gakkai Kaiho; 1994 Feb; 97(2):213-7. PubMed ID: 8169725
[TBL] [Abstract][Full Text] [Related]
34. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa.
Terada N; Konno A; Tada H; Shirotori K; Ishikawa K; Togawa K
J Allergy Clin Immunol; 1992 Aug; 90(2):160-8. PubMed ID: 1500623
[TBL] [Abstract][Full Text] [Related]
35. Chemokines in seasonal allergic rhinitis.
Kuna P; Lazarovich M; Kaplan AP
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):104-12. PubMed ID: 8568122
[TBL] [Abstract][Full Text] [Related]
36. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment.
Andersson M; Andersson P; Venge P; Pipkorn U
Allergy; 1989 Jul; 44(5):342-8. PubMed ID: 2669553
[TBL] [Abstract][Full Text] [Related]
37. Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis.
Di Gioacchino M; Cavallucci E; Di Sciascio MB; Di Stefano F; Verna N; Lobefalo L; Crudeli C; Volpe AR; Angelucci D; Cuccurullo F; Conti P
Immunobiology; 2000 Apr; 201(5):541-51. PubMed ID: 10834312
[TBL] [Abstract][Full Text] [Related]
38. Nasal tissue eosinophils in allergic rhinitis.
Masuyama K; Samejima Y; Ishikawa T
Auris Nasus Larynx; 1993; 20(3):205-13. PubMed ID: 8297268
[TBL] [Abstract][Full Text] [Related]
39. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx.
Bascom R; Pipkorn U; Proud D; Dunnette S; Gleich GJ; Lichtenstein LM; Naclerio RM
J Allergy Clin Immunol; 1989 Sep; 84(3):338-46. PubMed ID: 2778240
[TBL] [Abstract][Full Text] [Related]
40. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen.
Assanasen P; Baroody FM; Naureckas E; Naclerio RM
Clin Exp Allergy; 2001 Dec; 31(12):1913-22. PubMed ID: 11737044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
